首页 > 最新文献

Epidemiologie Mikrobiologie Imunologie最新文献

英文 中文
Tracking the dynamics of antibody production against the SARS-CoV-2 virus after two doses of the mRNA vaccine BNT162b2. 追踪两剂mRNA疫苗BNT162b2后SARS-CoV-2病毒抗体产生的动态。
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.61568/emi/11-6445/20250128/139686
M Malý, A Fialová, H Zákoucká, V Němeček, H Orlíková, J Kynčl, R Limberková
<p><strong>Objective: </strong>An observational study was conducted from 2021 to 2022 to track the dynamics of the production of IgG antibody against the SARS-CoV-2 S protein in individuals vaccinated with two doses of the Pfizer-BioNTech mRNA vaccine BNT162b2 (Comirnaty). The study included a group of volunteers without any previous signs of SARS-CoV-2 infection as well as a group with a history of natural COVID-19 infection. The primary objective was to monitor antibody levels up to 12 months after the second dose and determine the proportion of vaccinated individuals who underwent seroconversion. The study also evaluated cases of vaccine failure within 13 months post-vaccination.</p><p><strong>Methods: </strong>Before the vaccination began, participants had laboratory tests for IgG antibodies against the SARS-CoV-2 S protein, and their medical history related to COVID-19 was taken. Based on negative test results, a cohort of immunologically naïve individuals was formed and subsequently vaccinated with two doses of BNT162b2 (Comirnaty). Venous blood samples were collected at six time points: before the first dose, 2-3 weeks after the first dose, one month after the second dose, 3-4 months after the second dose, 6 months after the second dose, and 12 months after the second dose. A supplementary cohort included volunteers with positive antibody findings or confirmed COVID-19 infection. In some of these individuals, the dynamics of post-vaccination antibody response was also monitored. Participants filled out monthly questionnaires about respiratory infection symptoms to detect vaccine failure.</p><p><strong>Results: </strong>The study included 166 participants who did not have SARS-CoV-2 S protein antibodies prior to vaccination. The median age was 52 years, with a higher proportion of women (71.1%). After the first and second doses of the vaccine, antibody levels showed a significant increase, followed by a gradual decline over 12 months. Seroconversion occurred in all participants except for one immunosuppressed individual. The vaccine failure rate against COVID-19 within 12 months was 13.3%. The second cohort included 60 participants with prior SARS-CoV-2 infection. In this group, post-vaccination antibody levels increased significantly, more than in individuals without prior infection. The second dose did not result in further statistically significant increase in antibody levels for this cohort.</p><p><strong>Conclusions: </strong>The study confirmed that the BNT162b2 mRNA vaccine induces a strong antibody response, with the majority of participants experiencing seroconversion after the first dose. Older individuals exhibited a lower antibody response, highlighting the importance of booster doses. In individuals with prior SARS-CoV-2 infection, antibody levels were significantly higher after the first vaccine dose than in naïve individuals. These findings add to understanding antibody response dynamics and suggest the need for further resea
目的:从2021年到2022年进行一项观察性研究,追踪接种两剂辉瑞- biontech mRNA疫苗BNT162b2 (Comirnaty)的个体产生针对sars - cov - 2s蛋白的IgG抗体的动态。该研究包括一组没有任何SARS-CoV-2感染迹象的志愿者,以及一组有自然COVID-19感染史的志愿者。主要目的是监测第二次接种后12个月的抗体水平,并确定接受血清转化的接种者的比例。该研究还评估了疫苗接种后13个月内疫苗失败的病例。方法:接种疫苗前,对受试者进行sars - cov - 2s蛋白IgG抗体实验室检测,并采集与COVID-19相关的病史。根据阴性检测结果,形成免疫naïve个体队列,随后接种两剂BNT162b2 (Comirnaty)。在第一次给药前、第一次给药后2-3周、第二次给药后1个月、第二次给药后3-4个月、第二次给药后6个月、第二次给药后12个月采集静脉血。补充队列包括抗体阳性或确诊COVID-19感染的志愿者。在其中一些个体中,还监测了疫苗接种后抗体反应的动态。参与者每月填写关于呼吸道感染症状的问卷,以检测疫苗接种失败。结果:该研究纳入了166名在接种疫苗前没有sars - cov - 2s蛋白抗体的参与者。中位年龄为52岁,女性比例较高(71.1%)。在接种第一剂和第二剂疫苗后,抗体水平显著增加,随后在12个月内逐渐下降。除一名免疫抑制个体外,所有参与者均发生血清转化。12个月内COVID-19疫苗失败率为13.3%。第二组包括60名既往感染过SARS-CoV-2的参与者。在这一组中,接种疫苗后抗体水平显著升高,高于未感染的个体。在该队列中,第二次剂量没有导致抗体水平进一步的统计学显著增加。结论:该研究证实,BNT162b2 mRNA疫苗可诱导强烈的抗体应答,大多数参与者在首次接种后出现血清转化。老年人表现出较低的抗体反应,强调加强剂量的重要性。在先前感染过SARS-CoV-2的个体中,首次接种疫苗后抗体水平显著高于naïve个体。这些发现有助于理解抗体反应动力学,并表明需要进一步研究优化疫苗接种计划。
{"title":"Tracking the dynamics of antibody production against the SARS-CoV-2 virus after two doses of the mRNA vaccine BNT162b2.","authors":"M Malý, A Fialová, H Zákoucká, V Němeček, H Orlíková, J Kynčl, R Limberková","doi":"10.61568/emi/11-6445/20250128/139686","DOIUrl":"10.61568/emi/11-6445/20250128/139686","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;An observational study was conducted from 2021 to 2022 to track the dynamics of the production of IgG antibody against the SARS-CoV-2 S protein in individuals vaccinated with two doses of the Pfizer-BioNTech mRNA vaccine BNT162b2 (Comirnaty). The study included a group of volunteers without any previous signs of SARS-CoV-2 infection as well as a group with a history of natural COVID-19 infection. The primary objective was to monitor antibody levels up to 12 months after the second dose and determine the proportion of vaccinated individuals who underwent seroconversion. The study also evaluated cases of vaccine failure within 13 months post-vaccination.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Before the vaccination began, participants had laboratory tests for IgG antibodies against the SARS-CoV-2 S protein, and their medical history related to COVID-19 was taken. Based on negative test results, a cohort of immunologically naïve individuals was formed and subsequently vaccinated with two doses of BNT162b2 (Comirnaty). Venous blood samples were collected at six time points: before the first dose, 2-3 weeks after the first dose, one month after the second dose, 3-4 months after the second dose, 6 months after the second dose, and 12 months after the second dose. A supplementary cohort included volunteers with positive antibody findings or confirmed COVID-19 infection. In some of these individuals, the dynamics of post-vaccination antibody response was also monitored. Participants filled out monthly questionnaires about respiratory infection symptoms to detect vaccine failure.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The study included 166 participants who did not have SARS-CoV-2 S protein antibodies prior to vaccination. The median age was 52 years, with a higher proportion of women (71.1%). After the first and second doses of the vaccine, antibody levels showed a significant increase, followed by a gradual decline over 12 months. Seroconversion occurred in all participants except for one immunosuppressed individual. The vaccine failure rate against COVID-19 within 12 months was 13.3%. The second cohort included 60 participants with prior SARS-CoV-2 infection. In this group, post-vaccination antibody levels increased significantly, more than in individuals without prior infection. The second dose did not result in further statistically significant increase in antibody levels for this cohort.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The study confirmed that the BNT162b2 mRNA vaccine induces a strong antibody response, with the majority of participants experiencing seroconversion after the first dose. Older individuals exhibited a lower antibody response, highlighting the importance of booster doses. In individuals with prior SARS-CoV-2 infection, antibody levels were significantly higher after the first vaccine dose than in naïve individuals. These findings add to understanding antibody response dynamics and suggest the need for further resea","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"74 1","pages":"44-52"},"PeriodicalIF":0.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144217591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blastocystis in the human gastrointestinal tract - commensal or "silent" pathogen? 人胃肠道囊虫——共生病原体还是“沉默”病原体?
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.61568/emi/11-6492/20250428/140419
S Kühnelová, L Rožnovský, J Doležílková, R Maďar

Blastocystis is a unicellular anaerobic microorganism inhabiting the human and animal gastrointestinal tract (GIT). It is the most abundant representative of eukaryotes reported in human feces and found in approx. a billion people worldwide. Despite the common occurrence, its direct pathogenicity and status among other, more significant, GIT parasites remain unclear. Blastocystis colonization is associated with various non-specific clusters of symptoms, such as diarrhea, abdominal pain, flatulence, or nausea and is often diagnosed in patients with irritable bowel syndrome, ulcerative colitis, or urticaria. Controversy persists mainly because of the detection of Blastocystis even in asymptomatic patients and the unclear mechanism of its potential pathogenicity. Also, for the reasons mentioned above, no treatment guidelines are available.

囊虫是一种栖息在人和动物胃肠道(GIT)的单细胞厌氧微生物。它是据报道在人类粪便中最丰富的真核生物代表,在大约。全世界有十亿人。尽管常见,但其直接致病性和在其他更重要的GIT寄生虫中的地位尚不清楚。囊虫定植与各种非特异性症状群有关,如腹泻、腹痛、胀气或恶心,通常在肠易激综合征、溃疡性结肠炎或荨麻疹患者中诊断出来。争论持续的主要原因是即使在无症状的患者中也能检测到囊虫,以及其潜在致病性的机制尚不清楚。此外,由于上述原因,目前尚无治疗指南。
{"title":"Blastocystis in the human gastrointestinal tract - commensal or \"silent\" pathogen?","authors":"S Kühnelová, L Rožnovský, J Doležílková, R Maďar","doi":"10.61568/emi/11-6492/20250428/140419","DOIUrl":"10.61568/emi/11-6492/20250428/140419","url":null,"abstract":"<p><p>Blastocystis is a unicellular anaerobic microorganism inhabiting the human and animal gastrointestinal tract (GIT). It is the most abundant representative of eukaryotes reported in human feces and found in approx. a billion people worldwide. Despite the common occurrence, its direct pathogenicity and status among other, more significant, GIT parasites remain unclear. Blastocystis colonization is associated with various non-specific clusters of symptoms, such as diarrhea, abdominal pain, flatulence, or nausea and is often diagnosed in patients with irritable bowel syndrome, ulcerative colitis, or urticaria. Controversy persists mainly because of the detection of Blastocystis even in asymptomatic patients and the unclear mechanism of its potential pathogenicity. Also, for the reasons mentioned above, no treatment guidelines are available.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"74 2","pages":"118-125"},"PeriodicalIF":0.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144762338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccination in pregnancy - a study in maternity hospitals of the Pilsen Region, Czech Republic. 妊娠期疫苗接种——在捷克共和国皮尔森地区妇产医院进行的一项研究。
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.61568/emi/11-6568/20250808/141315
P Pazdiora, H Jelínková, M Kozerovský, P Hubáček

Aim: Vaccination in pregnancy is an important preventive measure against a number of infections. Since the vaccination coverage data for pregnant women in the Czech Republic are scarce, a study was carried out in the Pilsen Region.

Material and methods: In the 6-week Postpartum Care Centres of the Gynaecology and Obstetrics Clinic of the Pilsen University Hospital and the Gynaecology and Obstetrics Departments of the Klatovy and Domažlice Hospitals, between 1 October and 31 December 2024, postpartum mothers were asked to fill out printed questionnaires to collect basic data on an anonymous basis (age group, education level, region of residence, information about the possibility of vaccination against influenza, COVID-19, respiratory syncytial virus (RSV) infections, and pertussis, its completion during pregnancy, and specialty of the informing health professional). Questionnaire data were entered into the Epi-Info database to be analysed. The χ2 test was used for statistical testing at a significance level of 5%.

Results: In the three-month study period, 836 women gave birth at the above-listed clinics and 313 (37.4%) of them completed the questionnaire. Of the total number of respondents, 85 women (27.2%) were vaccinated with at least one of the four vaccines during pregnancy, varying from 21.9 to 28.3% between centres. Receiving influenza vaccine, COVID-19 vaccine and RSV vaccine, and pertussis vaccine was reported by 1.6%, 1.3%, and 25.9% of postpartum mothers, respectively. The highest vaccination coverage was found in the 30-39 year age group and in women with tertiary education. Pertussis vaccine was recommended to pregnant women most often (47.6%) in comparison with COVID-19 vaccine mentioned least often. Of the 85 vaccinated women, 76 (24.3%) had at least 1 vaccine on recommendation. Information about the possibility of vaccination was most often provided by gynaecologists and adult general practitioners. Vaccination against the listed respiratory infections was reported quite rarely by women without prior information: only nine pregnant women (2.9%) did so.

Conclusions: The study in maternity hospitals in the Pilsen Region confirmed low vaccination coverage in pregnancy. At the same time, information on the importance of vaccination appeared to be inadequate, especially regarding the prevention of RSV and COVID-19 infection. Gynaecologists are currently the most frequent source of information. The unfavourable situation can be improved by joint expert opinion of medical societies and by raising awareness of the general population on this issue.

目的:孕期接种疫苗是预防多种感染的重要措施。由于捷克共和国孕妇的疫苗接种覆盖率数据很少,因此在皮尔森地区进行了一项研究。材料和方法:2024年10月1日至12月31日期间,在皮尔森大学医院妇产科诊所的产后6周护理中心以及克拉托维医院和Domažlice医院的妇产科,要求产后母亲填写打印的问卷,以匿名方式收集基本数据(年龄、教育程度、居住地区、关于接种流感疫苗的可能性的信息、COVID-19、呼吸道合胞病毒(RSV)感染和百日咳,其在怀孕期间的完成,以及告知卫生专业人员的专业)。问卷数据被输入Epi-Info数据库进行分析。统计学检验采用χ2检验,显著性水平为5%。结果:在三个月的研究期间,共有836名妇女在上述诊所分娩,其中313名(37.4%)妇女完成了问卷调查。在答复者总数中,85名妇女(27.2%)在怀孕期间至少接种了四种疫苗中的一种,各中心之间的比例从21.9%到28.3%不等。产后母亲接种流感疫苗、COVID-19疫苗和RSV疫苗、百日咳疫苗的比例分别为1.6%、1.3%和25.9%。疫苗接种覆盖率最高的是30-39岁年龄组和受过高等教育的妇女。孕妇最常被推荐接种百日咳疫苗(47.6%),而COVID-19疫苗被推荐的频率最低。在85名接种疫苗的妇女中,76名(24.3%)至少接种了一种推荐疫苗。关于接种疫苗可能性的信息通常是由妇科医生和成年全科医生提供的。没有事先信息的妇女很少报告针对所列呼吸道感染的疫苗接种:只有9名孕妇(2.9%)这样做了。结论:在皮尔森地区妇产医院进行的研究证实,妊娠期疫苗接种率低。与此同时,关于疫苗接种重要性的信息似乎不足,特别是在预防呼吸道合胞病毒和COVID-19感染方面。妇科医生是目前最常见的信息来源。通过医学协会的联合专家意见和提高一般民众对这一问题的认识,可以改善这种不利状况。
{"title":"Vaccination in pregnancy - a study in maternity hospitals of the Pilsen Region, Czech Republic.","authors":"P Pazdiora, H Jelínková, M Kozerovský, P Hubáček","doi":"10.61568/emi/11-6568/20250808/141315","DOIUrl":"https://doi.org/10.61568/emi/11-6568/20250808/141315","url":null,"abstract":"<p><strong>Aim: </strong>Vaccination in pregnancy is an important preventive measure against a number of infections. Since the vaccination coverage data for pregnant women in the Czech Republic are scarce, a study was carried out in the Pilsen Region.</p><p><strong>Material and methods: </strong>In the 6-week Postpartum Care Centres of the Gynaecology and Obstetrics Clinic of the Pilsen University Hospital and the Gynaecology and Obstetrics Departments of the Klatovy and Domažlice Hospitals, between 1 October and 31 December 2024, postpartum mothers were asked to fill out printed questionnaires to collect basic data on an anonymous basis (age group, education level, region of residence, information about the possibility of vaccination against influenza, COVID-19, respiratory syncytial virus (RSV) infections, and pertussis, its completion during pregnancy, and specialty of the informing health professional). Questionnaire data were entered into the Epi-Info database to be analysed. The χ2 test was used for statistical testing at a significance level of 5%.</p><p><strong>Results: </strong>In the three-month study period, 836 women gave birth at the above-listed clinics and 313 (37.4%) of them completed the questionnaire. Of the total number of respondents, 85 women (27.2%) were vaccinated with at least one of the four vaccines during pregnancy, varying from 21.9 to 28.3% between centres. Receiving influenza vaccine, COVID-19 vaccine and RSV vaccine, and pertussis vaccine was reported by 1.6%, 1.3%, and 25.9% of postpartum mothers, respectively. The highest vaccination coverage was found in the 30-39 year age group and in women with tertiary education. Pertussis vaccine was recommended to pregnant women most often (47.6%) in comparison with COVID-19 vaccine mentioned least often. Of the 85 vaccinated women, 76 (24.3%) had at least 1 vaccine on recommendation. Information about the possibility of vaccination was most often provided by gynaecologists and adult general practitioners. Vaccination against the listed respiratory infections was reported quite rarely by women without prior information: only nine pregnant women (2.9%) did so.</p><p><strong>Conclusions: </strong>The study in maternity hospitals in the Pilsen Region confirmed low vaccination coverage in pregnancy. At the same time, information on the importance of vaccination appeared to be inadequate, especially regarding the prevention of RSV and COVID-19 infection. Gynaecologists are currently the most frequent source of information. The unfavourable situation can be improved by joint expert opinion of medical societies and by raising awareness of the general population on this issue.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"74 3","pages":"158-165"},"PeriodicalIF":0.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145240431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological characteristics of human leptospirosis in Slovak Republic, 2008-2019. 2008-2019年斯洛伐克共和国人钩端螺旋体病流行病学特征
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.61568/emi/11-6568/20250808/141313
J Perželová, M Kotrbancová, M Fulová, A Bražinová

Aim of study: The purpose of this study was observation of some epidemiological characteristics of human leptospirosis in Slovakia during 2008-2019.

Materials and methods: Patients' data analysed in this work were obtained from laboratory diagnostic and trawling questionnaires. The diagnosis of acute leptospirosis was confirmed by the serological examination in the micro-agglutination test in accordance with clinical and epidemiological data. Statistical analyses were performed by software STATA version 18 (StataCorp LP, College Station, TX, USA).

Results: Average annual incidence rate in Slovakia in the study period was 0.185/100,000 population. Case-fatality rate was 2.48% due to three fatal cases. The infection affected more men (80.16%) than women (19.84%) mostly in the age of 20-69 years old with the peak in 50-59 years old. Almost three quarters of affected persons were people without professional exposure. The highest number of cases was recorded in the period from June to November, peaking in August (25.62%). The most cases of infections were reported from administrative regions Košice (23.14%) and Trenčín (22.31%).

Conclusions: Incidence rate of human leptospirosis maintains the declining character in the study period, which has been present in recent decades in Slovakia. The numbers are most likely underreported, due to the misdiagnosing of leptospirosis cases caused by broad spectrum of clinical manifestations and low awareness of clinicians of possible diseases etiology.

研究目的:本研究的目的是观察2008-2019年斯洛伐克人钩端螺旋体病的一些流行病学特征。材料和方法:本研究分析的患者数据来自实验室诊断和拖网问卷调查。结合临床及流行病学资料,经微量凝集试验血清学检查,确诊为急性钩端螺旋体病。统计分析采用STATA version 18软件(StataCorp LP, College Station, TX, USA)。结果:斯洛伐克研究期间年平均发病率为0.185/10万人。病死率2.48%,死亡3例。男性感染率(80.16%)高于女性(19.84%),主要发生在20 ~ 69岁,50 ~ 59岁为高峰。近四分之三的受影响的人没有专业经验。6月至11月录得个案最多,8月为高峰(25.62%)。感染病例以Košice(23.14%)和Trenčín(22.31%)行政区域最多。结论:斯洛伐克人钩端螺旋体病发病率在研究期间呈下降趋势,近几十年来一直呈下降趋势。由于广泛的临床表现和临床医生对可能的疾病病因的认识不足,钩端螺旋体病病例被误诊,这些数字很可能被低估。
{"title":"Epidemiological characteristics of human leptospirosis in Slovak Republic, 2008-2019.","authors":"J Perželová, M Kotrbancová, M Fulová, A Bražinová","doi":"10.61568/emi/11-6568/20250808/141313","DOIUrl":"https://doi.org/10.61568/emi/11-6568/20250808/141313","url":null,"abstract":"<p><strong>Aim of study: </strong>The purpose of this study was observation of some epidemiological characteristics of human leptospirosis in Slovakia during 2008-2019.</p><p><strong>Materials and methods: </strong>Patients' data analysed in this work were obtained from laboratory diagnostic and trawling questionnaires. The diagnosis of acute leptospirosis was confirmed by the serological examination in the micro-agglutination test in accordance with clinical and epidemiological data. Statistical analyses were performed by software STATA version 18 (StataCorp LP, College Station, TX, USA).</p><p><strong>Results: </strong>Average annual incidence rate in Slovakia in the study period was 0.185/100,000 population. Case-fatality rate was 2.48% due to three fatal cases. The infection affected more men (80.16%) than women (19.84%) mostly in the age of 20-69 years old with the peak in 50-59 years old. Almost three quarters of affected persons were people without professional exposure. The highest number of cases was recorded in the period from June to November, peaking in August (25.62%). The most cases of infections were reported from administrative regions Košice (23.14%) and Trenčín (22.31%).</p><p><strong>Conclusions: </strong>Incidence rate of human leptospirosis maintains the declining character in the study period, which has been present in recent decades in Slovakia. The numbers are most likely underreported, due to the misdiagnosing of leptospirosis cases caused by broad spectrum of clinical manifestations and low awareness of clinicians of possible diseases etiology.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"74 3","pages":"141-148"},"PeriodicalIF":0.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145240444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shigellosis: an update on the disease and analysis of human cases in the Czech Republic, 2018-2023. 志贺氏菌病:2018-2023年捷克共和国人间病例的最新情况和分析
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.61568/emi/11-6445/20250128/139685
M Špačková, J Košťálová, A Pierzynová, R Chlíbek
<p><strong>Introduction: </strong>Shigellosis is a highly contagious diarrheal disease, which could potentially be very serious. Considering the onethird increase in cases in 2023 compared to the previous year, we aimed to provide an update on the disease and to analyse data on reported cases of shigellosis in the Czech Republic (CZ).</p><p><strong>Methods: </strong>We conducted a narrative search of the literature in Czech and English, particularly targeting European studies from 2018 onwards. We also analysed data reported under the diagnosis code A03 to the National Infectious Disease Reporting System (ISIN) in 2018-2023. We focused on the main epidemiological indicators, i.e. gender, age, geographical distribution, seasonality, and hospitalizations. Excel (version 2016), STATA (version 17), and Datawrapper GmbH were used.</p><p><strong>Results: </strong>A total of 681 shigellosis cases were reported with an average annual incidence of 1/100,000 population: until 2021, the incidence was slightly higher in women, while from 2022 onwards, the trend was reversed. A significant decrease in cases was recorded in the pandemic years. In 2022 and 2023, the number of cases was slightly higher than in the pre-pandemic period. Most cases were detected in CZ in August and December each year. Of all shigella serotypes, S. sonnei was the most frequently detected (80%), followed by S. flexneri (15%). The incidence per 100.000 population was highest among children aged 5-9 years: 2.6 (boys 2.4 and girls 2.8), followed by 1-4-year-olds: 2.4 (2.2 and 2.6, respectively) and persons aged 25-34 years: 1.8 (males 1.8 and females 1.7). Within individual age group, the average annual specific incidence rates were highest in the Moravian-Silesian and Olomouc regions and the capital city Prague. Hospitalizations accounted for 27% of cases, with the highest numbers in the 25-34 and 5-9 age groups (both 17.9%). The proportion of hospitalized cases was highest in the age groups 75+ (69%), 1-4, 5-9, and 65-74 (32-37%). A 52-year-old man was reported to have die in relation to the disease. Eleven percent of cases were reported in outbreak settings. Thirty-nine percent of reported cases were imported.</p><p><strong>Conclusions: </strong>In CZ, shigellosis is a relatively rare gastrointestinal disease, with nearly 40% of cases being imported. At present, the threat to public health is posed mainly by the global spread of multi-resistant strains linked to increasing tourism and free sexual practices. Children, immunocompromised persons (including the elderly), and men who have sex with men remain risk groups. Vaccination is not available in Europe. Compliance with basic hygiene rules, especially in collectives and when working with food, is still a key concern. Emphasis should also be placed on the health education, including instructions before traveling abroad. A thorough medical history, early tracing, surveillance, and rational choice of antibiotic therapy if appropriate a
志贺氏菌病是一种高度传染性腹泻疾病,可能非常严重。考虑到2023年的病例比前一年增加三分之一,我们的目标是提供该病的最新情况,并分析捷克共和国(CZ)报告的志贺氏菌病病例数据。方法:我们对捷克语和英语的文献进行了叙述性检索,特别是针对2018年以来的欧洲研究。我们还分析了2018-2023年以诊断代码A03向国家传染病报告系统(ISIN)报告的数据。我们关注主要流行病学指标,即性别、年龄、地理分布、季节性和住院情况。使用Excel (version 2016)、STATA (version 17)和Datawrapper GmbH。结果:共报告志贺氏菌病病例681例,年平均发病率为10万人中的1/10,到2021年,女性发病率略高,而从2022年起,趋势发生逆转。在大流行年份,病例显著减少。在2022年和2023年,病例数略高于大流行前时期。疫区病例以每年8月和12月为主。在所有志贺氏菌血清型中,sonnei最常被检测到(80%),其次是flexneri(15%)。每10万人中发病率最高的是5-9岁儿童:2.6例(男孩2.4例,女孩2.8例),其次是1-4岁儿童:2.4例(分别为2.2例和2.6例),25-34岁儿童:1.8例(男性1.8例,女性1.7例)。在各个年龄组中,摩拉维亚-西里西亚和奥洛穆茨地区以及首都布拉格的平均年具体发病率最高。住院治疗占病例总数的27%,25-34岁和5-9岁年龄组的人数最多(均为17.9%)。住院病例的比例在75岁以上(69%)、1-4岁、5-9岁和65-74岁(32-37%)年龄组中最高。据报一名52岁男子死于该疾病。11%的病例是在爆发环境中报告的。39%的报告病例是输入性的。结论:在CZ,志贺氏菌病是一种较为罕见的胃肠道疾病,近40%的病例为输入性病例。目前,对公共卫生的威胁主要是与日益增加的旅游业和自由的性行为有关的多重耐药菌株的全球传播。儿童、免疫功能低下者(包括老年人)和男男性行为者仍然是危险群体。欧洲没有疫苗接种。遵守基本卫生规则,特别是在集体和处理食品时,仍然是一个关键问题。还应重视健康教育,包括出国旅行前的指导。全面的病史、早期追踪、监测和合理选择抗生素治疗是必要的。在CZ,所有疑似菌株都要送到NRL进行确认。所有分离株均应进行全基因组测序和抗生素药敏试验。
{"title":"Shigellosis: an update on the disease and analysis of human cases in the Czech Republic, 2018-2023.","authors":"M Špačková, J Košťálová, A Pierzynová, R Chlíbek","doi":"10.61568/emi/11-6445/20250128/139685","DOIUrl":"https://doi.org/10.61568/emi/11-6445/20250128/139685","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Shigellosis is a highly contagious diarrheal disease, which could potentially be very serious. Considering the onethird increase in cases in 2023 compared to the previous year, we aimed to provide an update on the disease and to analyse data on reported cases of shigellosis in the Czech Republic (CZ).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We conducted a narrative search of the literature in Czech and English, particularly targeting European studies from 2018 onwards. We also analysed data reported under the diagnosis code A03 to the National Infectious Disease Reporting System (ISIN) in 2018-2023. We focused on the main epidemiological indicators, i.e. gender, age, geographical distribution, seasonality, and hospitalizations. Excel (version 2016), STATA (version 17), and Datawrapper GmbH were used.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 681 shigellosis cases were reported with an average annual incidence of 1/100,000 population: until 2021, the incidence was slightly higher in women, while from 2022 onwards, the trend was reversed. A significant decrease in cases was recorded in the pandemic years. In 2022 and 2023, the number of cases was slightly higher than in the pre-pandemic period. Most cases were detected in CZ in August and December each year. Of all shigella serotypes, S. sonnei was the most frequently detected (80%), followed by S. flexneri (15%). The incidence per 100.000 population was highest among children aged 5-9 years: 2.6 (boys 2.4 and girls 2.8), followed by 1-4-year-olds: 2.4 (2.2 and 2.6, respectively) and persons aged 25-34 years: 1.8 (males 1.8 and females 1.7). Within individual age group, the average annual specific incidence rates were highest in the Moravian-Silesian and Olomouc regions and the capital city Prague. Hospitalizations accounted for 27% of cases, with the highest numbers in the 25-34 and 5-9 age groups (both 17.9%). The proportion of hospitalized cases was highest in the age groups 75+ (69%), 1-4, 5-9, and 65-74 (32-37%). A 52-year-old man was reported to have die in relation to the disease. Eleven percent of cases were reported in outbreak settings. Thirty-nine percent of reported cases were imported.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;In CZ, shigellosis is a relatively rare gastrointestinal disease, with nearly 40% of cases being imported. At present, the threat to public health is posed mainly by the global spread of multi-resistant strains linked to increasing tourism and free sexual practices. Children, immunocompromised persons (including the elderly), and men who have sex with men remain risk groups. Vaccination is not available in Europe. Compliance with basic hygiene rules, especially in collectives and when working with food, is still a key concern. Emphasis should also be placed on the health education, including instructions before traveling abroad. A thorough medical history, early tracing, surveillance, and rational choice of antibiotic therapy if appropriate a","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"74 1","pages":"31-43"},"PeriodicalIF":0.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144217588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toxoplasmosis - seroprevalence and trend over 10 years. 弓形虫病——10年来的血清患病率和趋势。
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.61568/emi/11-6445/20250128/139683
J Ficik

Objective: Determination of the seroprevalence of toxoplasmosis in patients tested in the network Unilabs Slovakia Ltd over 10 years (2011-2020).

Material and methods: In the study period, 142,088 patients from all over Slovakia underwent targeted serological screening for toxoplasmosis. Serum samples were tested for IgG and IgM antibodies by electrochemiluminescence assays. A total of 469,824 of tests were performed during the study period in three central laboratories of the Alpha Medical company (now Unilabs Slovakia Ltd) located in Bratislava, Ružomberok-Likavka, and Stropkov.

Results: The seroprevalence of toxoplasmosis has shown a slightly upward trend (for IgM antibodies), remaining stable for IgG class antibodies, neither declining nor rising. An upward trend in positive IgM antibodies appeared not only in general, but also in pregnant women. When calculated per 100,000 population, the IgG seroprevalence has shown an upward 10-year trend for the whole of Slovakia.

Conclusion: The results of this study have evidenced that toxoplasmosis is far from declining in Slovakia; just on the contrary, it can be reasonably assumed that its incidence is slowly rising, especially among pregnant women, which, from the point of view of public health, is worthy of further and more detailed investigation.

目的:测定10年来(2011-2020年)Unilabs斯洛伐克有限公司网络检测的患者血清弓形虫病的患病率。材料和方法:在研究期间,来自斯洛伐克各地的142,088名患者接受了弓形虫病的靶向血清学筛查。采用电化学发光法检测血清IgG和IgM抗体。在研究期间,在位于布拉迪斯拉发、Ružomberok-Likavka和斯特罗普科夫的Alpha医疗公司(现为Unilabs斯洛伐克有限公司)的三个中心实验室共进行了469,824次试验。结果:弓形虫病血清阳性率(IgM类抗体)呈轻微上升趋势,IgG类抗体保持稳定,既不下降也不上升。IgM抗体阳性率不仅在一般人群中呈上升趋势,而且在孕妇中也有上升趋势。按每10万人计算,10年来整个斯洛伐克的IgG血清流行率呈上升趋势。结论:本研究结果表明,斯洛伐克弓形虫病远未减少;恰恰相反,可以合理地假设,其发病率正在缓慢上升,特别是在孕妇中,从公共卫生的角度来看,这值得进一步和更详细的调查。
{"title":"Toxoplasmosis - seroprevalence and trend over 10 years.","authors":"J Ficik","doi":"10.61568/emi/11-6445/20250128/139683","DOIUrl":"https://doi.org/10.61568/emi/11-6445/20250128/139683","url":null,"abstract":"<p><strong>Objective: </strong>Determination of the seroprevalence of toxoplasmosis in patients tested in the network Unilabs Slovakia Ltd over 10 years (2011-2020).</p><p><strong>Material and methods: </strong>In the study period, 142,088 patients from all over Slovakia underwent targeted serological screening for toxoplasmosis. Serum samples were tested for IgG and IgM antibodies by electrochemiluminescence assays. A total of 469,824 of tests were performed during the study period in three central laboratories of the Alpha Medical company (now Unilabs Slovakia Ltd) located in Bratislava, Ružomberok-Likavka, and Stropkov.</p><p><strong>Results: </strong>The seroprevalence of toxoplasmosis has shown a slightly upward trend (for IgM antibodies), remaining stable for IgG class antibodies, neither declining nor rising. An upward trend in positive IgM antibodies appeared not only in general, but also in pregnant women. When calculated per 100,000 population, the IgG seroprevalence has shown an upward 10-year trend for the whole of Slovakia.</p><p><strong>Conclusion: </strong>The results of this study have evidenced that toxoplasmosis is far from declining in Slovakia; just on the contrary, it can be reasonably assumed that its incidence is slowly rising, especially among pregnant women, which, from the point of view of public health, is worthy of further and more detailed investigation.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"74 1","pages":"11-19"},"PeriodicalIF":0.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144217590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microbial contamination of air filters of air conditioning system of urban buses. 城市客车空调系统空气过滤器微生物污染。
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.61568/emi/11-6492/20250428/140416
D Obitková, C Čereiová, M Mráz, E Pavlík

The use of HVAC in urban buses in developed countries increases the comfort and indoor air quality in the means of ground transportation. The microbial contamination was studied on outlet and inlet surfaces of 5 air filters removed from the urban buses HVAC during regular maintenance. To acquire samples from both the outlet and the inlet sides of the filters, dry swabbing technique was used. Cultivation was performed on different selective or selective-diagnostic agars, to cultivate viable bacteria. To identify the bacterial species, Gram stain and immerse microscopy was used. Selected colonies underwent the proteomic study (MALDI-TOF) as well. After identification, bacteria were quantified. The bacteria of the genus Bacillus - Bacillus cereus, Bacillus subtilis, Bacillus licheniformis, Bacillus pumilus, Bacillus flexus prevailed on both inlet and outlet surfaces of the filters. The members of genera Staphylococcus, Brevibacillus, Peribacillus or Paenibacillus were also identified. The quantification of colony forming units showed low contamination of the outlet surfaces of filters 1 and 2. The contamination of inlet and outlet sides of filters 3, 4, and 5 was comparable, revealed nearly the same contamination of inlet and outlet surfaces. In the case of filters 3, 4 and 5 we recommend more frequent filter changing or more efficient filter choice.

发达国家在城市公交车上使用暖通空调,提高了地面交通工具的舒适性和室内空气质量。对定期检修时从城市公交车暖通空调上拆下的5个空气过滤器的出风口表面和进风口表面进行了微生物污染研究。为了从过滤器的出口和进口两侧获取样本,使用了干拭子技术。在不同的选择性或选择性诊断琼脂上进行培养,培养活菌。采用革兰氏染色法和浸泡镜检法鉴定细菌种类。选择的菌落也进行了蛋白质组学研究(MALDI-TOF)。鉴定后对细菌进行定量。芽孢杆菌属细菌-蜡样芽孢杆菌、枯草芽孢杆菌、地衣芽孢杆菌、细芽孢杆菌、弯曲芽孢杆菌在过滤器的入口和出口表面均占主导地位。还鉴定了葡萄球菌属、短芽孢杆菌属、芽孢杆菌属和芽孢杆菌属的成员。菌落形成单元的定量分析表明,1号和2号滤池的出口表面污染程度较低。过滤器3、4和5的进口和出口两侧的污染具有可比性,表明进口和出口表面的污染几乎相同。在过滤器3、4和5的情况下,我们建议更频繁地更换过滤器或选择更有效的过滤器。
{"title":"Microbial contamination of air filters of air conditioning system of urban buses.","authors":"D Obitková, C Čereiová, M Mráz, E Pavlík","doi":"10.61568/emi/11-6492/20250428/140416","DOIUrl":"https://doi.org/10.61568/emi/11-6492/20250428/140416","url":null,"abstract":"<p><p>The use of HVAC in urban buses in developed countries increases the comfort and indoor air quality in the means of ground transportation. The microbial contamination was studied on outlet and inlet surfaces of 5 air filters removed from the urban buses HVAC during regular maintenance. To acquire samples from both the outlet and the inlet sides of the filters, dry swabbing technique was used. Cultivation was performed on different selective or selective-diagnostic agars, to cultivate viable bacteria. To identify the bacterial species, Gram stain and immerse microscopy was used. Selected colonies underwent the proteomic study (MALDI-TOF) as well. After identification, bacteria were quantified. The bacteria of the genus Bacillus - Bacillus cereus, Bacillus subtilis, Bacillus licheniformis, Bacillus pumilus, Bacillus flexus prevailed on both inlet and outlet surfaces of the filters. The members of genera Staphylococcus, Brevibacillus, Peribacillus or Paenibacillus were also identified. The quantification of colony forming units showed low contamination of the outlet surfaces of filters 1 and 2. The contamination of inlet and outlet sides of filters 3, 4, and 5 was comparable, revealed nearly the same contamination of inlet and outlet surfaces. In the case of filters 3, 4 and 5 we recommend more frequent filter changing or more efficient filter choice.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"74 2","pages":"107-112"},"PeriodicalIF":0.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144762341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The first autochthonous case of diphyllobothriosis, caused by broad fish tapeworm (Dibothriocephalus latus), in the Czech Republic. 捷克共和国由阔鱼绦虫(Dibothriocephalus latus)引起的第一例本地双叶绦虫病。
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.61568/emi/11-6445/20250128/139689
T Scholz, R Kuchta, J Brabec, V Pavelková, Z Lapáčková

Diphyllobothriosis is a parasitic infection of humans caused by the broad fish tapeworm (Dibothriocephalus latus; synonym Diphyllobothrium latum). This disease is widespread in the Northern Hemisphere including Europe. Popular sport fish such as perch (Perca fluviatilis) and pike (Esox lucius) are the source of human infection. Here we document the first autochthonous case of diphyllobothriosis linked to the consumption of raw pike roe (caviar) originating from a popular tourist destination in South Bohemia. This is probably a recent introduction of the parasite into the Lipno Reservoir, which may represent a new focus of diphyllobothriosis, a zoonotic, fish-borne disease.

双头绦虫病是一种由阔鱼绦虫(Dibothriocephalus latus;二叶菌的同义词)。这种疾病在包括欧洲在内的北半球广泛传播。流行的运动鱼类,如鲈鱼和梭子鱼是人类感染的来源。在这里,我们记录了与食用原产于南波西米亚一个热门旅游目的地的生梭子子(鱼子酱)有关的第一例本地双叶螺旋体病。这可能是最近将该寄生虫引入利普诺水库,这可能代表了一种人畜共患的鱼媒疾病——双叶螺旋体病的新焦点。
{"title":"The first autochthonous case of diphyllobothriosis, caused by broad fish tapeworm (Dibothriocephalus latus), in the Czech Republic.","authors":"T Scholz, R Kuchta, J Brabec, V Pavelková, Z Lapáčková","doi":"10.61568/emi/11-6445/20250128/139689","DOIUrl":"10.61568/emi/11-6445/20250128/139689","url":null,"abstract":"<p><p>Diphyllobothriosis is a parasitic infection of humans caused by the broad fish tapeworm (Dibothriocephalus latus; synonym Diphyllobothrium latum). This disease is widespread in the Northern Hemisphere including Europe. Popular sport fish such as perch (Perca fluviatilis) and pike (Esox lucius) are the source of human infection. Here we document the first autochthonous case of diphyllobothriosis linked to the consumption of raw pike roe (caviar) originating from a popular tourist destination in South Bohemia. This is probably a recent introduction of the parasite into the Lipno Reservoir, which may represent a new focus of diphyllobothriosis, a zoonotic, fish-borne disease.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"74 1","pages":"76-79"},"PeriodicalIF":0.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144217589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A lethal tick-borne encephalitis from an active endemic area in Slovakia. 斯洛伐克流行地区的一种致命蜱传脑炎。
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.61568/emi/11-6492/20250428/140418
S Litvová, M Štefkovičová, M Greždová, A Drľová, Z Krištúfková, M Kopilec Garabášová

Tick-borne encephalitis (TBE) is a neglected zoonotic neuroinvasive disease. Most cases of TBE have a mild course, but some patients with encephalitis develop long-term neurological or neuropsychic sequelae. We report a fatal case of TBE in a patient living in an endemic area. The case occurred in a middle-aged man with no epidemiological evidence of tick bites, no consumption of raw dairy products, and who was not vaccinated against TBE. The aim of this paper is to draw attention to the need for better information of the risk factors associated with TBE with the long-term sequelae, to improve case management and to stimulate the development of new vaccination strategies. To our knowledge, this is the first reported case of rare fatal TBE in a middle-aged man with no severe comorbidities in Slovakia.

蜱传脑炎(TBE)是一种被忽视的人畜共患神经侵袭性疾病。大多数脑炎病例病程较轻,但有些脑炎患者会出现长期的神经或神经精神后遗症。我们报告一个致命的病例TBE患者生活在一个流行地区。该病例发生于一名中年男子,无蜱叮咬流行病学证据,未食用生乳制品,未接种TBE疫苗。本文的目的是提请人们注意需要更好地了解与TBE及其长期后遗症相关的风险因素,以改善病例管理并促进新的疫苗接种策略的发展。据我们所知,这是斯洛伐克首次报道的中年男子罕见致命性TBE病例,无严重合并症。
{"title":"A lethal tick-borne encephalitis from an active endemic area in Slovakia.","authors":"S Litvová, M Štefkovičová, M Greždová, A Drľová, Z Krištúfková, M Kopilec Garabášová","doi":"10.61568/emi/11-6492/20250428/140418","DOIUrl":"https://doi.org/10.61568/emi/11-6492/20250428/140418","url":null,"abstract":"<p><p>Tick-borne encephalitis (TBE) is a neglected zoonotic neuroinvasive disease. Most cases of TBE have a mild course, but some patients with encephalitis develop long-term neurological or neuropsychic sequelae. We report a fatal case of TBE in a patient living in an endemic area. The case occurred in a middle-aged man with no epidemiological evidence of tick bites, no consumption of raw dairy products, and who was not vaccinated against TBE. The aim of this paper is to draw attention to the need for better information of the risk factors associated with TBE with the long-term sequelae, to improve case management and to stimulate the development of new vaccination strategies. To our knowledge, this is the first reported case of rare fatal TBE in a middle-aged man with no severe comorbidities in Slovakia.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"74 2","pages":"126-130"},"PeriodicalIF":0.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144762292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pertussis surveillance data from the South Moravian Region, 2024. 南摩拉维亚地区的百日咳监测数据,2024年。
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.61568/emi/11-6568/20250808/141314
V Šponiar Ovesná, R Ciupek, R Boháčová

Introduction: Pertussis is a highly infectious respiratory disease caused by the bacterium Bordetella pertussis, which still occurs in both the paediatric and adult population despite a continuous high vaccine coverage. In 2024, a significant increase in pertussis was found in the Czech Republic.

Material and methods: The aim was to describe the incidence of pertussis in the South Moravian Region (SMR) in 2024 based on data from the Infectious Disease Information System and to analyse basic epidemiological indicators including vaccination status.

Results: In the South Moravian Region, 3,524 cases of pertussis (287.3/100,000) were reported in 2024, with the highest number of cases (20.1%) in the 15-19 age group. Although 89.2% of patients were vaccinated, active transmission of Bordetella pertussis persisted in the population, mainly due to immunity waning and frequent subclinical forms of the disease in adolescents and adults. The most severe course of the disease was observed in infants under 1 year of age, with a high proportion of hospital admissions.

Conclusion: The dramatic increase in pertussis in 2024 was related to a combination of factors: a weakening protective effect of vaccines, genetic adaptation of the causative agent, improved laboratory diagnosis, increased awareness of both the professional and general public, and reduced circulation of pertussis in the population as a result of the COVID-19 pandemic control measures. For effective control of pertussis, it is essential to promote regular booster doses of pertussis vaccine, to improve diagnosis, and to raise awareness of the population on the importance of protecting the most vulnerable groups, especially infants.

简介:百日咳是一种由百日咳博德泰拉细菌引起的高度传染性呼吸道疾病,尽管疫苗覆盖率一直很高,但仍发生在儿科和成人人群中。2024年,捷克共和国发现百日咳病例显著增加。材料和方法:目的是根据传染病信息系统的数据描述2024年南摩拉维亚地区百日咳的发病率,并分析包括疫苗接种状况在内的基本流行病学指标。结果:南摩拉维亚地区2024年报告百日咳3524例(287.3/10万),15-19岁年龄组的病例数最多(20.1%)。尽管89.2%的患者接种了疫苗,但百日咳博德泰拉在人群中持续活跃传播,主要是由于免疫力下降和青少年和成人中常见的亚临床形式的疾病。在1岁以下的婴儿中观察到最严重的病程,住院率很高。结论:2024年百日咳病例的急剧增加与疫苗保护作用减弱、病原体的遗传适应性、实验室诊断水平的提高、专业和公众意识的提高以及COVID-19大流行控制措施导致的人群百日咳循环减少等因素有关。为了有效控制百日咳,必须促进定期加强百日咳疫苗剂量,改善诊断,并提高人们对保护最脆弱群体,特别是婴儿重要性的认识。
{"title":"Pertussis surveillance data from the South Moravian Region, 2024.","authors":"V Šponiar Ovesná, R Ciupek, R Boháčová","doi":"10.61568/emi/11-6568/20250808/141314","DOIUrl":"https://doi.org/10.61568/emi/11-6568/20250808/141314","url":null,"abstract":"<p><strong>Introduction: </strong>Pertussis is a highly infectious respiratory disease caused by the bacterium Bordetella pertussis, which still occurs in both the paediatric and adult population despite a continuous high vaccine coverage. In 2024, a significant increase in pertussis was found in the Czech Republic.</p><p><strong>Material and methods: </strong>The aim was to describe the incidence of pertussis in the South Moravian Region (SMR) in 2024 based on data from the Infectious Disease Information System and to analyse basic epidemiological indicators including vaccination status.</p><p><strong>Results: </strong>In the South Moravian Region, 3,524 cases of pertussis (287.3/100,000) were reported in 2024, with the highest number of cases (20.1%) in the 15-19 age group. Although 89.2% of patients were vaccinated, active transmission of Bordetella pertussis persisted in the population, mainly due to immunity waning and frequent subclinical forms of the disease in adolescents and adults. The most severe course of the disease was observed in infants under 1 year of age, with a high proportion of hospital admissions.</p><p><strong>Conclusion: </strong>The dramatic increase in pertussis in 2024 was related to a combination of factors: a weakening protective effect of vaccines, genetic adaptation of the causative agent, improved laboratory diagnosis, increased awareness of both the professional and general public, and reduced circulation of pertussis in the population as a result of the COVID-19 pandemic control measures. For effective control of pertussis, it is essential to promote regular booster doses of pertussis vaccine, to improve diagnosis, and to raise awareness of the population on the importance of protecting the most vulnerable groups, especially infants.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"74 3","pages":"149-157"},"PeriodicalIF":0.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145240439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Epidemiologie Mikrobiologie Imunologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1